Newcells Biotech Raises Further £2.35M in Funding

▤ Summary

Newcells Biotech, a Newcastle, London, UK-based company which specializes in 3D models, raised $2.35M in funding. Led by Dr. Mike Nicholds, CEO, Newcells offers a 3D models that mimic processes within the body and are used by pharmaceutical companies worldwide to test the impact of their drugs, including their efficacy and safety. It provides data to support critical decisions, such as whether to continue development and commence human trials. Newcells currently offers models of the retina, kidney and lung and also provides specialist services to run customised tests. Customers include pharmaceutical companies which use its products for applications ranging from gene therapy efficacy to toxicity screening, and a major research consortium.

▦ Linked Companies